Infants under 6 months of age who have a first-degree relative with celiac are eligible to join the CDGEMM Study to understand the many factors that contribute to the development of celiac.
Latiglutenase is an enzyme supplement that helps digest gluten. While clinical studies have not proven it prevents damage to the small intestine, it did relieve the participants’ most common complaints of abdominal pain, bloating, fatigue and constipation.
Celiac hospitalization costs $7.4 million annually in the U.S., safe sourdough for celiac patients and more in this roundup of recent research news in the gluten-free community.
Learn three ways to campaign for the kind of celiac research that could lead to better quality of life, pharmaceutical treatments and alternative therapies.
Read about the results of two recent studies into whether a common virus and cesarean section are celiac disease triggers.
A recent study found family members who care for celiac patients face a significant emotional burden, with a greater risk for depression and anxiety.
People with celiac disease have a higher risk for thyroid disease, according to recent research. Learn the signs to watch for and when to see a doctor.
Infants under 6 months of age who have a first-degree relative with celiac disease are eligible to join the CDGEMM Study to understand the many factors that contribute to the development of celiac disease.
Keeping up with news about research into celiac disease, gluten-intolerance, the gluten-free diet and related topics can keep you very…